# NRX-101 Expanded Access

> **NCT05779267** · — · AVAILABLE · sponsor: **NeuroRx, Inc.**

## Conditions studied

- Bipolar Depression
- Bipolar Affective Disorder

## Interventions

- **DRUG:** NRX-101

## Key facts

- **NCT ID:** NCT05779267
- **Lead sponsor:** NeuroRx, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2023-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05779267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05779267, "NRX-101 Expanded Access". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05779267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*